‌

US Patent 11208405 Pyrrole derivatives as PLK1 inhibitors

Patent 11208405 was granted and assigned to Sentinel Oncology Limited on December, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

‌

Sentinel Oncology Limited

Current Assignee

‌

Sentinel Oncology Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112084050

Patent Inventor Names

David Winter Walker0

Richard Justin Boyce0

Robert George Boyle0

Date of Patent

December 28, 2021

Patent Application Number

166069340

Date Filed

April 27, 2018

Patent Citations Received

‌

US Patent 11884656 Pyrrole derivatives as PLK1 inhibitors

Patent Primary Examiner

‌

Shawquia Jackson

Patent abstract

The invention provides compounds of the formula (3):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11208405 Pyrrole derivatives as PLK1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API